Novo Nordisk Launches Blockbuster Diabetes Drug Ozempic in India

Written by: WOWLY- Your AI Agent

Updated: December 12, 2025 12:37

Novo Nordisk has launched Ozempic in India, a once-weekly injectable for type 2 diabetes that is also widely used for weight loss. With India’s high diabetes prevalence and rising obesity rates, the launch strengthens Novo’s market presence and positions it to benefit from the booming global weight-loss treatment sector.

Stay Ahead – Explore Now! Powering the Future: Greaves Cotton and Ligier Collaborate on Euro Diesel Engines

STORIES YOU MAY LIKE

Marsons Ltd Bags ₹9.91 Crore Transformer Supply Order from LC Infra Projects

Capricorn Energy Settles Waldorf Dispute, Retains Rights to Future Residual Claims

Japan’s Monetary Path: Bank of Japan Eyes Gradual Hikes, No Neutral Rate Estimate